Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens. End Quote

(1888PressRelease) July 06, 2022 - Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses.

Monkeypox virus (MPV or MPXV) is a double-stranded DNA virus that causes monkeypox in humans and other animals. It belongs to the genus Orthopoxvirus in the family Poxviridae, which is one of the human Orthopoxviruses that include variola (VARV), cowpox (CPX), and vaccinia (VACV) viruses. It is not a direct ancestor to, nor a direct descendant of, the variola virus, which causes smallpox. Rather, monkeypox disease is similar to smallpox but has a milder rash and lower mortality rate. Variation in virulence of the virus has been observed in isolates from Central Africa, where strains are more virulent than those from Western Africa. The two areas have distinct clades of viruses, termed Congo Basin (Central African) and West African clades.

Monkeypox virus can be spread among animals and humans through direct contact with the body fluids or through bite transfection of infected animals. The present outbreak has a toll of over 220 confirmed cases spreading across 19 countries. The U.K., Spain, and Portugal lead the pack with the highest number of confirmed cases. Creative Diagnostics has now developed several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses.

These new Monkeypox Virus Antibodies and Antigens revealed the best performance for MPXV research, as they're prepared in different hosts and are specific to Monkeypox Virus and other Orthopoxvirus. Most importantly, they can be used to identify Monkeypox Virus via ELISA and to develop diagnostic assays. It is noted that these products are intended for research and laboratory use only and are not for diagnostic or clinical use.

Products such as Mouse Anti-Monkeypox Virus Monoclonal antibody, clone 6D8 (CABT-CS618), Human Anti-Monkeypox Virus Monoclonal antibody, clone 6D8 (CABT-CS621), Recombinant Monkeypox Virus E8L Protein [His] (DAG-WT762), and Recombinant Monkeypox Virus E8L Protein [His] (DAG-WT762) are available at Creative Diagnostics.

In addition, Creative Diagnostics also provides a variety of antigens and antibodies of SARS-CoV-2, including SARS-CoV-2 mutant proteins, biotinylated proteins, SARS-CoV-2 antibody pairs, and neutralizing antibodies. These antigens and antibodies can be used for scientific research and the detection of SARS-CoV-2-specific antibodies.

If you want to know more details about Monkeypox Virus Antibodies and Antigens or have any questions regarding research materials, please visit Creative Diagnostics at https://www.creative-diagnostics.com.

About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. It also provides contract biologic R&D and manufacturing services to diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.

###

space

Other Related Press Releases